Budd among Ten Leading Innovators to Receive 2014 Lupus Research Institute Award
- By Jennifer Nachbur
University of Vermont Professor of Medicine Ralph Budd, M.D., has received a 2014 Lupus Research Institute (LRI) Award to study a new potential avenue for treating inflammation in lupus. He is one of ten investigators from across the country to be recognized with one of these grants, which support “high-risk, high-reward” research that aims to transform lupus treatments and advance patient care.
Established in 2000, the LRI is the nation’s only nonprofit organization solely dedicated to novel research in lupus, a chronic, autoimmune disease that can cause inflammation, pain, and damage in all parts of the body – including the skin, joints, and internal organs. The organization’s innovative research platform has generated more than $170 million for novel investigations in lupus over the past decade, resulting in discoveries that have directly impacted patient care.
The LRI Novel Research Grant Class of 2014 represents investigators from Florida to Seattle, working in areas ranging from genetics to the human biology of lupus, in an effort to identify new angles and pathways for addressing lupus.
Budd is among six 2014 grant recipients examining biological approaches to determining why the lupus immune system switches sides and begins attacking the body it is supposed to protect. Specifically, Budd’s research, titled “RIG-I Regulation of Interferon Signature in SLE,” will investigate if damaged mitochondria (the cell’s energy factories) promote inflammation in lupus, the findings from which could lead to new treatment approaches. Read more about Budd’s LRI grant.